| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 25,000 options
@ $0.3553, valued at
$8.9k
|
|
| 05/31/2023 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 5,357 shares
@ $0
Granted 22,500 options to buy
@ $11.2, valued at
$252k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 23,109 shares
@ $0
Sold 40 shares
@ $1.01, valued at
$40.4
Granted 34,663 options to buy
@ $1.01, valued at
$35k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Histogen Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.822, valued at
$16.4k
|
|
| 08/05/2021 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 7,500 options to buy
@ $4.44, valued at
$33.3k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 15,000 options
@ $2.94, valued at
$44.1k
|
|
| 06/11/2020 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.21, valued at
$78.2k
|
|
| 05/29/2020 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 25,000 options to buy
@ $4.84, valued at
$121k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.29, valued at
$5.8k
|
|
| 06/13/2019 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.5, valued at
$202.5k
|
|
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2019 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 15,000 options to buy
@ $4.97, valued at
$74.6k
|
|
| 06/25/2018 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.99, valued at
$99.8k
|
|
| 06/07/2018 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $11.3, valued at
$169.5k
|
|
| 06/01/2018 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 15,000 options to buy
@ $15.8, valued at
$237k
|
|
| 06/26/2017 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.96, valued at
$99.2k
|
|
| 06/09/2017 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $18.77, valued at
$281.6k
|
|
| 06/02/2017 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on DYNAVAX TECHNOLOGIES CORP|
Txns:
| Granted 7,500 options to buy
@ $5.9, valued at
$44.3k
|
|
| 12/30/2016 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc. |
| 12/30/2016 |
4/A
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc. |
| 12/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| KISNER DANIEL L (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.13, valued at
$42.6k
|
|
|